Company profile
The Immunology CRO
Immunology CRO specialising in experimental immunology, immune response and tissue damage analysis
Financial period: 1 Feb 2024 to 31 Jan 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQ0MDI1OTUxNWFkaXF6a2N4
Published 21 Oct 2024 07:59
Company registered at Companies House
1 Nov 2022 to 31 Oct 2024
1 Aug 2020 to 30 Jun 2021
There is a lack of models and biomarkers to predict the severity and outcome of a COVID-19 infection. Such biomarkers could help in predicting the expected intensive care beds that are needed. Importantly, there are few or no models to use in the laboratory that are safe, that can study the immunologic progression of viruses in a condition that does not i...
